Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20117132 20180160 1.76 78.4 Curative (C) 2018-07-10 2018-07-17 null 01 Y BEVACIZUMAB 101176873
20117727 20180161 1.53 83 Palliative (P) 2020-12-17 2021-01-07 null 02 N CARBOPLATIN + PACLITAXEL + RT 100676526
20121424 20180162 1.73 74.8 null 2020-06-16 2020-06-16 null 2 null PEMBROLIZUMAB 100191559
20121799 20180163 1.73 76.8 Disease modification (D) 2021-01-04 2021-01-10 null 02 N MITOMYCIN INTRAVESICULAR 101838727
20124005 20180165 1.65 null 03 2020-08-24 2021-02-20 null 2 N CISPLATIN + EPIRUBICIN + FLUOROURACIL 101570061
20124470 20180166 0 64.4 null 2021-04-04 2021-04-13 null 02 null CISPLATIN + ETOPOSIDE 100368605
20127387 20180167 1.55 null Palliative (P) 2020-10-19 2020-11-05 null 02 null CISPLATIN + EPIRUBICIN + FLUOROURACIL 100568877
20128425 20180168 0 54.6 Palliative (P) 2021-02-23 2021-02-23 null 2 N LENALIDOMIDE 101186030
20128758 20180169 1.63 57 Neo-adjuvant (N) 2022-03-06 2022-03-06 null N Y ATEZOLIZUMAB + BEVACIZUMAB 100056430
20130428 20180170 1.9 null null 2022-02-10 2022-02-12 null 02 null SUNITINIB 100859039
20131694 20180171 null 79.7 Curative (C) 2021-01-03 2021-09-29 null N N CETUXIMAB + ENCORAFENIB 101227084
20131904 20180172 1.7 89.8 Palliative (P) 2021-11-24 2021-11-28 null 02 N SCALOP-2 TRIAL 100112547
20131959 20180173 null null null 2018-02-19 2019-06-24 null 02 null OXALIPLATIN 101090541
20133526 20180174 1.69 90 null 2021-03-04 2021-04-07 null 02 null SCALOP-2 TRIAL 101369305
20134721 20180175 1.83 110 Palliative (P) 2019-07-11 2019-08-01 null 02 N OCTREOTIDE 100284389
20141745 20180176 1.91 85.5 Palliative (P) 2019-12-13 2019-12-17 null 02 Y CAPECITABINE + CISPLATIN + EPIRUBICIN 101465889
20143244 20180178 1.7 95.91 null 2016-05-16 2019-06-21 null 02 null CISPLATIN + EPIRUBICIN + FLUOROURACIL 100190619
20143370 20180179 1.78 67.8 Neo-adjuvant (N) 2017-01-31 2017-01-31 null 02 Y OCTREOTIDE 100028118
20143988 20180180 1.5 null Curative (C) null 2019-12-01 Bevacizumab + Irinotecan + MdG 02 null ERIBULIN 101187221
20148182 20180181 1.57 62.2 Palliative (P) 2020-01-17 2020-01-28 Capecitabine+Cisplatin+Streptozocin N N INTERAACT TRIAL 101627462
20148558 20180182 1.58 63.6 Curative (C) null 2021-06-26 ACTICCA-1 Trial null N AFATINIB 101213518
20152042 20180184 1.63 48 03 2017-06-23 2019-04-14 ESHAP N Y NAB-PACLITAXEL 100555245
20154024 20180185 1.56 75.1 null 2020-01-14 2020-05-13 EPIRUBICIN + FLUOROURACIL + OXALIPLATIN null null CARBOPLATIN + PEMETREXED 101388079
20155475 20180186 1.61 68 null 2021-01-25 2021-08-24 CAP + RT 01 null CABAZITAXEL 101204404
20157177 20180187 null null Curative (C) 2022-05-05 2022-05-18 CISPLATIN + FLUOROURACIL + RT N N CISPLATIN + DOCETAXEL + FLUOROURACIL 101243634
20157596 20180188 1.47 81.2 Palliative (P) 2018-03-13 2018-03-13 CAPECITABINE + IRINOTECAN + Panitumumab N null CISPLATIN + FLUOROURACIL + TRASTUZUMAB 100080821
20159094 20180189 1.74 71.9 Palliative (P) 2021-08-13 2022-03-25 ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE 02 N CISPLATIN + FU + TRASTUZUMAB 101121232
20159370 20180190 1.89 77 null 2021-10-13 2021-10-13 Bevacizumab + Irinotecan + MdG 02 N CAPECITABINE + DOCETAXEL 101429125
20169180 20180192 1.72 0 Adjuvant (A) 2017-12-24 2018-03-18 FOXTROT TRIAL 02 N BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB 100813839
20172887 20180194 null null null 2021-11-21 2021-12-04 CHOP R - 21 days 02 null CHLORAMBUCIL 101667430
20180926 20180196 1.65 47.6 null 2020-01-10 2020-01-12 Ripretinib 02 N CAPECITABINE + STREPTOZOCIN 100350853
20184308 20180199 1.9 76.7 Neo-adjuvant (N) 2021-11-26 2022-04-04 Letrozole + Palbociclib N N AZACITIDINE 100669532
20184820 20180200 1.86 65 Adjuvant (A) 2016-08-31 2016-09-01 MITOMYCIN 02 N PHITT 100129984
20186389 20180201 1.89 56.8 03 2020-06-07 2020-06-23 Gemcitabine + Paclitaxel 02 N CARBOPLATIN + RALTITREXED 101404371
20191722 20180202 1.8 60.8 null 2019-09-24 2019-09-25 EEF or EOF 02 null CAPE + OXALIPLATIN + TRASTUZUMAB 100789396
20193816 20180204 1.56 85.3 Palliative (P) 2020-01-02 2020-01-17 CISPLATIN + FLUOROURACIL + RT 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 100567206
20194172 20180205 1.51 80.3 Neo-adjuvant (N) 2017-09-28 2018-02-14 Hydroxycarbamide 02 N TOPOTECAN 100352389
20194533 20180206 1.61 106 null 2018-01-22 2018-02-13 SCOPE 2 TRIAL N null CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE 100062470
20197298 20180207 0.9 88.7 Palliative (P) 2021-10-14 2021-11-20 Bendamustine+Rituximab(Sub Courses) 02 null BEVACIZUMAB + FLUOROURACIL + IRINOTECAN 101227674
20197694 20180208 1.69 59.2 Palliative (P) 2020-03-09 2020-06-26 Cisplatin +FU +Trastuzumab - Maint 02 N PHITT 100150951
20198192 20180209 1.59 67.5 Adjuvant (A) 2019-11-28 2019-11-30 null 02 N ETOPOSIDE 100980667
20199648 20180210 null null Neo-adjuvant (N) 2021-08-04 2021-09-24 Temozolomide 200mg/m2 02 null EPIRUBICIN 100122884
20200823 20180211 1.75 66 Neo-adjuvant (N) 2019-01-02 2019-01-02 IDELALISIB + RITUXIMAB N null SCOPE 1 TRIAL 100337471
20201166 20180212 1.81 48.2 null 2019-06-18 2019-06-18 AFATINIB 02 null CARBOPLATIN + VINORELBINE 100687744
20201314 20180213 1.81 0 Palliative (P) 2018-11-01 2018-12-04 Hydroxycarbamide 02 N BACILLUS CALMETTE-GUERIN 101256435
20206048 20180218 1.51 74.4 Disease modification (D) null 2020-01-27 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB N null CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 101257517
20206119 20180219 1.75 25.5 03 2018-01-16 2018-02-13 Gemcitabine + RT pancreas 02 N DOXORUBICIN 100637538
20206443 20180220 1.69 null Palliative (P) 2018-11-27 2019-01-22 BCG Intravesical 02 N CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN 101450822
20206480 20180221 1.61 80.3 Palliative (P) 2018-09-23 2018-10-06 Capecitabine + Trastuzumab 02 N OLARATUMAB 100364677
20206530 20180222 1.6 55 Neo-adjuvant (N) 2019-09-11 2019-09-16 CHOP R - 21 days 02 N DARATUMUMAB 101395576